Table 1 Characteristics of the 31 study patients with early-stage uterine adenosarcoma
Variables | No. of patients (%) |
|---|---|
Age at diagnosis, median (range) | 44.5 (21–81 years) |
Largest tumor diameter, mean (range) | 4.66 (0.8–22.0 cm) |
FIGO 2009 stage | |
IA | 21 (67.7) |
IB | 8 (25.8) |
IC | 2 (6.5) |
Sarcomatous overgrowth | |
Present | 10 (32.3) |
Absent | 21 (67.7) |
Primary therapy | |
No hysterectomy | 7 (22.6) |
Hysterectomy | 24 (77.4) |
Adjuvant therapy | |
Chemotherapy | 5 (16.1) |
Radiotherapy | 1 (3.2) |
Hormone therapy | 1 (3.2) |
Total | 31 (100%) |